tradingkey.logo
tradingkey.logo
Search

Candel Therapeutics Inc

CADL
Add to Watchlist
9.560USD
-0.300-3.04%
Close 07-24 16:00ETQuotes delayed by 15 min
524.83MMarket Cap
LossP/E TTM

CADL Financials

See Candel Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Candel Therapeutics Inc Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-0.14/-0.32
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.72
58.61%
Analyst Rating
BUY
2026/07/26
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-197.21%-0.14
-35.84%-0.54
38.27%-0.21
87.49%-0.09
151.91%0.15
-3.28%-0.40
-14.02%-0.33
-123.87%-0.74
7.42%-0.28
-117.65%-0.38
---0.29
---0.33
---0.30
---0.18
---0.48
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
0.00%31.00K
0.00%31.00K
0.00%31.00K
0.00%31.00K
0.00%31.00K
0.00%31.00K
0.00%31.00K
Net Profit
-220.08%-8.86M
-109.59%-29.50M
-5.85%-11.27M
78.43%-4.80M
189.76%7.38M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
-118.28%-11.10M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.79M
-418.48%-5.08M
46.24%-8.69M
75.71%-4.15M
80.48%-874.00K
115.23%1.60M
-532.81%-16.16M
-493.88%-17.08M
Net Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
---16396.77%
---14586.17%
----
----
----
----
----
Gross Margin
----
----
----
----
----
----
----
----
----
----
----
----
----
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
123.79%23.51%
221.89%37.65%
-91.99%5.55%
-88.97%7.21%
-83.37%10.51%
-77.35%11.70%
63.97%69.32%
82.39%65.41%
102.76%63.18%
92.42%51.64%
--42.28%
--35.86%
--31.16%
--26.84%
--24.41%
----
----
----
----
----
Revenue
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
0.00%31.00K
0.00%31.00K
0.00%31.00K
0.00%31.00K
0.00%31.00K
0.00%31.00K
0.00%31.00K
Operating profit
-100.30%-16.28M
-92.40%-15.66M
-47.39%-12.91M
-30.40%-11.18M
-2.89%-8.13M
19.82%-8.14M
-1.25%-8.76M
10.41%-8.57M
17.87%-7.90M
-26.09%-10.15M
2.61%-8.65M
-9.30%-9.57M
-7.07%-9.62M
-6.09%-8.05M
-12.45%-8.88M
-86.39%-8.75M
-101.21%-8.99M
-27.07%-7.59M
-204.35%-7.90M
-90.66%-4.70M
Net Profit
-220.08%-8.86M
-109.59%-29.50M
-5.85%-11.27M
78.43%-4.80M
189.76%7.38M
-26.84%-14.07M
-26.21%-10.65M
-131.30%-22.24M
6.53%-8.22M
-118.28%-11.10M
2.91%-8.44M
-131.72%-9.61M
-906.29%-8.79M
-418.48%-5.08M
46.24%-8.69M
75.71%-4.15M
80.48%-874.00K
115.23%1.60M
-532.81%-16.16M
-493.88%-17.08M
Current assets
112.30%197.75M
16.94%121.39M
398.39%90.13M
355.72%103.61M
243.26%93.15M
182.10%103.80M
-59.90%18.09M
-57.39%22.73M
-56.14%27.14M
-48.85%36.80M
-42.96%45.10M
-38.89%53.36M
-35.31%61.88M
-15.30%71.94M
-13.06%79.07M
257.51%87.33M
224.54%95.65M
--84.94M
--90.95M
--24.43M
Total current liabilities
-64.87%7.05M
-76.03%9.00M
-28.42%10.93M
5.14%14.71M
48.25%20.07M
164.59%37.53M
47.85%15.27M
71.46%14.00M
158.54%13.54M
152.61%14.18M
75.09%10.33M
38.87%8.16M
-4.31%5.24M
4.72%5.62M
34.14%5.90M
30.80%5.88M
-0.47%5.47M
--5.36M
--4.40M
--4.49M
Total assets
110.54%201.92M
17.15%125.19M
335.00%93.60M
300.11%105.97M
207.22%95.91M
159.38%106.87M
-57.02%21.52M
-54.89%26.48M
-53.57%31.22M
-46.97%41.20M
-41.11%50.06M
-37.08%58.71M
-33.80%67.24M
-12.91%77.69M
-11.41%85.01M
203.48%93.30M
189.40%101.56M
--89.20M
--95.96M
--30.74M
Total liabilities
200.95%63.89M
80.75%73.27M
-63.36%13.47M
-56.78%15.76M
-15.88%21.23M
42.46%40.54M
36.00%36.77M
30.50%36.46M
-8.51%25.24M
-5.07%28.46M
-17.76%27.04M
-15.93%27.94M
-27.02%27.59M
19.58%29.98M
-0.28%32.88M
33.67%33.23M
179.36%37.80M
--25.07M
--32.97M
--24.86M
Total equity
84.84%138.03M
-21.72%51.92M
625.16%80.12M
1004.63%90.21M
1148.95%74.67M
420.42%66.33M
-166.27%-15.26M
-132.41%-9.97M
-84.92%5.98M
-73.29%12.74M
-55.83%23.02M
-48.78%30.77M
-37.81%39.65M
-25.61%47.71M
-17.24%52.13M
920.76%60.07M
195.70%63.76M
--64.14M
--62.99M
--5.88M
Net operating income
-109.34%-18.04M
-81.77%-10.57M
-55.73%-10.24M
-43.45%-8.89M
-2.11%-8.62M
21.67%-5.81M
25.37%-6.57M
13.86%-6.20M
22.01%-8.44M
-7.80%-7.42M
6.14%-8.81M
-1.38%-7.20M
-34.35%-10.82M
-31.44%-6.88M
-36.12%-9.38M
-59.16%-7.10M
-43.11%-8.05M
-53.34%-5.24M
-358.07%-6.89M
-130.32%-4.46M
Net investment
-22400.00%-675.00K
-13533.33%-409.00K
---117.00K
-416.67%-31.00K
57.14%-3.00K
88.89%-3.00K
100.00%0.00
96.45%-6.00K
-136.84%-7.00K
90.22%-27.00K
52.09%-103.00K
73.39%-169.00K
111.11%19.00K
45.24%-276.00K
45.15%-215.00K
10.56%-635.00K
25.33%-171.00K
-102.50%-504.00K
46.45%-392.00K
-156.32%-710.00K
Net financing
5116.84%93.81M
-52.24%43.90M
-301.01%-3.37M
796.86%17.44M
-49.00%-1.87M
76061.16%91.91M
--1.68M
--1.94M
---1.25M
-436.11%-121.00K
--0.00
-100.00%0.00
-100.00%0.00
--36.00K
-100.00%0.00
-93.39%22.00K
17682.14%19.92M
-100.00%0.00
--71.36M
-27.61%333.00K

FAQs

What are the current assets of Candel Therapeutics Inc?

According to Candel Therapeutics Inc's FY2025 earnings report, its current assets were 121.39M, with a year-on-year change of 16.94.

What are the total assets of Candel Therapeutics Inc?

According to Candel Therapeutics Inc's FY2025 earnings report, its total assets of Candel Therapeutics Inc were 125.19M, with a year-on-year change of 17.15.

What are the total liabilities of Candel Therapeutics Inc?

According to Candel Therapeutics Inc's FY2025 earnings report, its total liabilities of Candel Therapeutics Inc were 73.27M, with a year-on-year change of 80.75.

What is the total equity of Candel Therapeutics Inc?

According to Candel Therapeutics Inc's FY2025 earnings report, its total equity of Candel Therapeutics Inc was 51.92M, with a year-on-year change of -21.72.

What is the net operating income of Candel Therapeutics Inc?

According to Candel Therapeutics Inc's FY2025 earnings report, its net operating income of Candel Therapeutics Inc was -47.88M, with a year-on-year change of -43.47.

What is the net investment of Candel Therapeutics Inc?

According to Candel Therapeutics Inc's FY2025 earnings report, its net investment of Candel Therapeutics Inc was -560.00K, with a year-on-year change of -3400.00.

What is the net financing of Candel Therapeutics Inc?

According to Candel Therapeutics Inc's FY2025 earnings report, its net financing of Candel Therapeutics Inc was 56.10M, with a year-on-year change of -40.50.

What is the Earnings Per Share (EPS) of Candel Therapeutics Inc?

According to Candel Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.72, with a year-on-year change of 58.61.

What is the net income of Candel Therapeutics Inc?

According to Candel Therapeutics Inc's FY2025 earnings report, its net income was -38.18M, with a year-on-year change of 30.80.

What is the debt-to-asset ratio of Candel Therapeutics Inc?

According to Candel Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 37.65, with a year-on-year change of 221.89.

What is the Return on Equity (ROE) of Candel Therapeutics Inc?

According to Candel Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -64.58, with a year-on-year change of 53.73.

What is the Return on Assets (ROA) of Candel Therapeutics Inc?

According to Candel Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -32.91, with a year-on-year change of 55.85.

What is the operating profit of Candel Therapeutics Inc?

According to Candel Therapeutics Inc's FY2025 earnings report, its operating profit was -47.88M, with a year-on-year change of -43.47.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.